Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Nederlands Tijdschrift Voor Geneeskunde|April 20, 2023
[An exceptional venous pattern in a patient with cancer]Mira D Franken, Heike Röckmann-Helmbach, Rhodé M Bijlsma
Nederlands Tijdschrift Voor Geneeskunde|July 25, 2018
Unsolicited genomic findings in daily clinical practiceRoel H P Wouters, Rhodé M Bijlsma, Emile E Voest, et al.
Nederlands Tijdschrift Voor Geneeskunde|May 1, 2019
[Ethical dilemmas in a general practitioner's clinic due to incidental findings resulting from whole genome sequencing]Roel H P Wouters, Rhodé M Bijlsma, Emile E Voest, et al.
Breast Cancer Research and Treatment|October 26, 2023
European quality indicators developed by the European Commission Initiative on Breast Cancer: a first nationwide assessment for the Dutch settingKay Schreuder, Tim J Bult, Babet Stroop, et al.
European Journal of Human Genetics : EJHG|April 14, 2016
Unsolicited findings of next-generation sequencing for tumor analysis within a Dutch consortium: clinical daily practice reconsideredRhodé M Bijlsma, Annelien L Bredenoord, Christa G Gadellaa-Hooijdonk, et al.
Human Mutation|September 21, 2016
Am I My Family's Keeper? Disclosure Dilemmas in Next-Generation SequencingRoel H P Wouters, Rhodé M Bijlsma, Margreet G E M Ausems, et al.
Familial Cancer|August 31, 2017
Cancer patients' intentions towards receiving unsolicited genetic information obtained using next-generation sequencingRhodé M Bijlsma, Hester Wessels, Roel H P Wouters, et al.
Trends in Molecular Medicine|December 17, 2017
Is It Our Duty To Hunt for Pathogenic Mutations?Roel H P Wouters, Rhodé M Bijlsma, Geert W J Frederix, et al.
Cancers|November 21, 2020
Incidence, Survival, and Mortality Trends of Cancers Diagnosed in Adolescents and Young Adults (15-39 Years): A Population-Based Study in The Netherlands 1990-2016Daniël J van der Meer, Henrike E Karim-Kos, Marianne van der Mark, et al.
European Heart Journal Open|September 10, 2025
Morning administration of anthracyclines is associated with a lower risk of cancer therapy-related cardiac dysfunctionMarkella I Printezi, Arco J Teske, Nicolaas P A Zuithoff, et al.
Pageof 4